The global polyglactin 910 sutures market is expected to grow at a CAGR of 5.5% during the forecast period, to reach USD 1.2 billion by 2030. The growth of this market can be attributed to the increasing number of surgeries and rising demand for minimally invasive procedures, which are less painful and have shorter recovery periods than traditional surgeries.
The uncoated PGLA sutures segment is expected to account for the largest share in the global polyglactin 910 sutures market during the forecast period, owing to its low cost and easy availability in developing countries such as India and China. The coated PGLA sutures segment is expected to grow at a higher CAGR during the forecast period due to its increased biocompatibility with tissues, reduced risk of infection, improved wound healing rates, and enhanced tissue adhesion properties.
Hospitals accounted for the largest share in this market in 2017 owing to their high usage rate among surgeons who prefer using them over other types of surgical threads due their ease-of-use features such as quick knotting ability and minimal visibility under an operating microscope or endoscope. Hospitals are also preferred by surgeons because they offer better sterility conditions than clinics or ambulatory surgical centers (ASCs).
Some Of The Growth Factors Of This Market:
- Increasing number of surgeries and rising demand for minimally invasive procedures are driving the growth of the Polyglactin 910 Sutures market globally.
- Rising awareness about minimally invasive procedures and increasing number of surgeries are driving the growth of the Polyglactin 910 Sutures market globally.
Industry Growth Insights published a new data on “Polyglactin 910 Sutures (PGLA Sutures) Market”. The research report is titled “Polyglactin 910 Sutures (PGLA Sutures) Market research by Types (Uncoated PGLA Sutures, Coated PGLA Sutures), By Applications (Hospitals, Clinics, Ambulatory Surgical Centers, Others), By Players/Companies Medtronic, Boston Scientific, Johnson & Johnson, Smith & Nephew, B. Braun Melsungen, Demetech, Peters Surgical, Sutures India, Dolphin Sutures, Internacional Farmaceutica”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Polyglactin 910 Sutures (PGLA Sutures) Market Research Report
By Type
Uncoated PGLA Sutures, Coated PGLA Sutures
By Application
Hospitals, Clinics, Ambulatory Surgical Centers, Others
By Companies
Medtronic, Boston Scientific, Johnson & Johnson, Smith & Nephew, B. Braun Melsungen, Demetech, Peters Surgical, Sutures India, Dolphin Sutures, Internacional Farmaceutica
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
246
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
 Industry Outlook.svg)
Global Polyglactin 910 Sutures (PGLA Sutures) Market Report Segments:
The global Polyglactin 910 Sutures (PGLA Sutures) market is segmented on the basis of:
Types
Uncoated PGLA Sutures, Coated PGLA Sutures
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Ambulatory Surgical Centers, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Medtronic
- Boston Scientific
- Johnson & Johnson
- Smith & Nephew
- B. Braun Melsungen
- Demetech
- Peters Surgical
- Sutures India
- Dolphin Sutures
- Internacional Farmaceutica
 Market Overview.svg)
Highlights of The Polyglactin 910 Sutures (PGLA Sutures) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Uncoated PGLA Sutures
- Coated PGLA Sutures
- By Application:
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Polyglactin 910 Sutures (PGLA Sutures) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Polyglactin 910 is a synthetic polymer that has been used in medical procedures to close wounds. It is a type of suture made from multiple strands of polymers that are twisted together.
Some of the major companies in the polyglactin 910 sutures (pgla sutures) market are Medtronic, Boston Scientific, Johnson & Johnson, Smith & Nephew, B. Braun Melsungen, Demetech, Peters Surgical, Sutures India, Dolphin Sutures, Internacional Farmaceutica.
The polyglactin 910 sutures (pgla sutures) market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Polyglactin 910 Sutures (PGLA Sutures) Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Polyglactin 910 Sutures (PGLA Sutures) Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Polyglactin 910 Sutures (PGLA Sutures) Market - Supply Chain
4.5. Global Polyglactin 910 Sutures (PGLA Sutures) Market Forecast
4.5.1. Polyglactin 910 Sutures (PGLA Sutures) Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Polyglactin 910 Sutures (PGLA Sutures) Market Size (000 Units) and Y-o-Y Growth
4.5.3. Polyglactin 910 Sutures (PGLA Sutures) Market Absolute $ Opportunity
5. Global Polyglactin 910 Sutures (PGLA Sutures) Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Polyglactin 910 Sutures (PGLA Sutures) Market Size and Volume Forecast by Type
5.3.1. Uncoated PGLA Sutures
5.3.2. Coated PGLA Sutures
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Polyglactin 910 Sutures (PGLA Sutures) Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Polyglactin 910 Sutures (PGLA Sutures) Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Clinics
6.3.3. Ambulatory Surgical Centers
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Polyglactin 910 Sutures (PGLA Sutures) Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Polyglactin 910 Sutures (PGLA Sutures) Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Polyglactin 910 Sutures (PGLA Sutures) Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Polyglactin 910 Sutures (PGLA Sutures) Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Polyglactin 910 Sutures (PGLA Sutures) Demand Share Forecast, 2019-2026
9. North America Polyglactin 910 Sutures (PGLA Sutures) Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Polyglactin 910 Sutures (PGLA Sutures) Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Polyglactin 910 Sutures (PGLA Sutures) Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Clinics
9.4.3. Ambulatory Surgical Centers
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Polyglactin 910 Sutures (PGLA Sutures) Market Size and Volume Forecast by Type
9.7.1. Uncoated PGLA Sutures
9.7.2. Coated PGLA Sutures
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Polyglactin 910 Sutures (PGLA Sutures) Demand Share Forecast, 2019-2026
10. Latin America Polyglactin 910 Sutures (PGLA Sutures) Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Polyglactin 910 Sutures (PGLA Sutures) Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Polyglactin 910 Sutures (PGLA Sutures) Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Clinics
10.4.3. Ambulatory Surgical Centers
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Polyglactin 910 Sutures (PGLA Sutures) Market Size and Volume Forecast by Type
10.7.1. Uncoated PGLA Sutures
10.7.2. Coated PGLA Sutures
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Polyglactin 910 Sutures (PGLA Sutures) Demand Share Forecast, 2019-2026
11. Europe Polyglactin 910 Sutures (PGLA Sutures) Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Polyglactin 910 Sutures (PGLA Sutures) Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Polyglactin 910 Sutures (PGLA Sutures) Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Clinics
11.4.3. Ambulatory Surgical Centers
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Polyglactin 910 Sutures (PGLA Sutures) Market Size and Volume Forecast by Type
11.7.1. Uncoated PGLA Sutures
11.7.2. Coated PGLA Sutures
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Polyglactin 910 Sutures (PGLA Sutures) Demand Share, 2019-2026
12. Asia Pacific Polyglactin 910 Sutures (PGLA Sutures) Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Polyglactin 910 Sutures (PGLA Sutures) Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Polyglactin 910 Sutures (PGLA Sutures) Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Clinics
12.4.3. Ambulatory Surgical Centers
12.4.4. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Polyglactin 910 Sutures (PGLA Sutures) Market Size and Volume Forecast by Type
12.7.1. Uncoated PGLA Sutures
12.7.2. Coated PGLA Sutures
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Polyglactin 910 Sutures (PGLA Sutures) Demand Share, 2019-2026
13. Middle East & Africa Polyglactin 910 Sutures (PGLA Sutures) Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Polyglactin 910 Sutures (PGLA Sutures) Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Polyglactin 910 Sutures (PGLA Sutures) Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Clinics
13.4.3. Ambulatory Surgical Centers
13.4.4. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Polyglactin 910 Sutures (PGLA Sutures) Market Size and Volume Forecast by Type
13.7.1. Uncoated PGLA Sutures
13.7.2. Coated PGLA Sutures
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Polyglactin 910 Sutures (PGLA Sutures) Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Polyglactin 910 Sutures (PGLA Sutures) Market: Market Share Analysis
14.2. Polyglactin 910 Sutures (PGLA Sutures) Distributors and Customers
14.3. Polyglactin 910 Sutures (PGLA Sutures) Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Medtronic
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Boston Scientific
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Johnson & Johnson
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Smith & Nephew
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. B. Braun Melsungen
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Demetech
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Peters Surgical
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Sutures India
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Dolphin Sutures
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Internacional Farmaceutica
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
